- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Emerging Potential: Changing Lives One Story, One Therapeutic at a Time
The 2023 Emerging Pharma Leaders share with the Pharmaceutical Executive editors what makes a good leader, what has made them the proudest in their career, lessons they wish they had known when starting out, and more. (This is the audio-only Pharm Exec Podcast episode!)
Each year, Pharmaceutical Executive recognizes up-and-coming leaders who are vital to the future of the pharmaceutical and biotech industry in the Emerging Pharma Leaders (EPL) Awards. Nominations are judged by three members of the Editorial Advisory Board as well as a former EPL representative. This year, five winners were selected, all of whom had incredible journeys to share with the editorial team.
The Pharm Exec team would like to congratulate the 2023 Emerging Pharma Leaders:
- Natasha A. Hernday, chief business officer, Seagen
- Simon Holland, vice president, women's health commercial lead, Organon
- Justin To, chief operating officer, skeletal dysplasias and gene therapy, Bridge Bio
- Frank Watanabe, president and CEO, Arcutis Biotherapeutics
- Hanadie Yousef, PhD, co-founder and CEO, Juvena Therapeutics
In this episode of the Pharm Exec Podcast, Meg Rivers, managing editor, and the editorial team speak with the EPL winners, asking each about:
- Their current role and responsibilities
- What makes a good leader
- What has made them the proudest in their career
- Lessons they wish they had known when starting out
- What’s next for them in their career
Sponsor
Watch the video version of this podcast
Read about the 2023 Emerging Pharma Leaders
- Natasha A. Hernday, chief business officer, Seagen
- Simon Holland, vice president, women's health commercial lead, Organon
- Justin To, chief operating officer, skeletal dysplasias and gene therapy, Bridge Bio
- Frank Watanabe, president and CEO, Arcutis Biotherapeutics
- Hanadie Yousef, PhD, co-founder and CEO, Juvena Therapeutics
About the Pharm Exec Podcast
The editors of Pharmaceutical Executive bring you the latest commercial insights to master the science of success. Podcast episodes examine current trends, key conferences, and critical topics in the bio/pharmaceutical industry.
Listen to this podcast on SoundCloud, Spotify, Google Podcasts, or Apple Podcasts.
Beyond the Birthrate: The Societal Costs of Maternal Mortality
September 6th 2024Head of Medical Affairs and Outcomes Research at Organon, Charlotte Owens, MD, FACOG, discusses the most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make.
